Delayed Presentation of Basal Cell Carcinoma: A Case Report

被引:1
作者
Abadin, Andre A. [1 ]
Fosko, Scott [2 ]
Boniface, Michael [3 ]
Presutti, Richard J. [4 ]
机构
[1] Mayo Clin, Family Med, Jacksonville, FL 32224 USA
[2] Univ Florida, Dermatol, Gainesville, FL USA
[3] Mayo Clinc, Emergency Med, Jacksonville, FL USA
[4] Mayo Clin, Med, Jacksonville, FL 32224 USA
关键词
basal cell carcinoma; skin cancer; bcc; malignant; indolent skin lesion; DIAGNOSIS; CANCER;
D O I
10.7759/cureus.10695
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Basal cell carcinoma (BCC) is the most common skin cancer in the United States. Although BCC has a low metastatic potential, it can be locally invasive and destructive, especially when there is a delay in diagnosis or treatment. This can affect not only the surrounding skin, but deeper tissues including muscle, cartilage, and even bone. Primary care physicians often serve as the first line of defense in the recognition, diagnosis, and even treatment of skin lesions suspicious for BCC. Most low-risk BCC can be treated in the primary care office with electro-desiccation and curettage or surgical excision. We present a case of locally invasive BCC with significant soft tissue destruction of the neck, which was incidentally identified during an emergency department presentation for a myocardial infarction. It is the responsibility of primary care physicians to recognize the appearance of skin lesions suspicious for BCC and initiate or arrange for subsequent definitive diagnosis and treatment. Our intent in presenting this case is to illustrate a missed opportunity for earlier recognition and treatment because of lack of access to primary care, as well as to demonstrate the destructive nature of BCC when neglected over time. Comprehensive approaches to diagnosis and treatment are described elsewhere.
引用
收藏
页数:6
相关论文
共 19 条
[1]   Delayed treatment and continued growth of nonmelanoma skin cancer [J].
Alam, Murad ;
Goldberg, Leonard H. ;
Silapun, Sirunya ;
Gardner, Erin S. ;
Strom, Sara S. ;
Rademaker, Alfred W. ;
Margolis, David J. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (05) :839-848
[2]  
[Anonymous], 2010, CANC FACTS FIG 2010
[3]   Screening for Skin Cancer US Preventive Services Task Force Recommendation Statement [J].
Bibbins-Domingo, Kirsten ;
Grossman, David C. ;
Curry, Susan J. ;
Davidson, Karina W. ;
Ebell, Mark ;
Epling, John W., Jr. ;
Garcia, Francisco A. R. ;
Gillman, Matthew W. ;
Kemper, Alex R. ;
Krist, Alex H. ;
Kurth, Ann E. ;
Landefeld, C. Seth ;
Mangione, Carol M. ;
Phillips, William R. ;
Phipps, Maureen G. ;
Pignone, Michael P. ;
Siu, Albert L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (04) :429-435
[4]   Guidelines of care for the management of basal cell carcinoma [J].
Bichakjian, Christopher ;
Armstrong, April ;
Baum, Christi ;
Bordeaux, Jeremy S. ;
Brown, Marc ;
Busam, Klaus J. ;
Eisen, Daniel B. ;
Iyengar, Vivek ;
Lober, Clifford ;
Margolis, David J. ;
Messina, Jane ;
Miller, Alexander ;
Miller, Stanley ;
Mostow, Eliot ;
Mowad, Christen ;
Nehal, Kishwer ;
Schmitt-Burr, Kristi ;
Sekulic, Aleksandar ;
Storrs, Paul ;
Teng, Joyce ;
Yu, Siegrid ;
Huang, Conway ;
Boyer, Kevin ;
Begolka, Wendy Smith ;
Alam, Murad ;
Kim, John Y. S. ;
Kozlow, Jeffrey H. ;
Mittal, Bharat ;
Moyer, Jeffrey ;
Olencki, Thomas ;
Rodgers, Phillip .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) :540-559
[5]   Basal cell carcinoma Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations [J].
Cameron, Michael C. ;
Lee, Erica ;
Hibler, Brian P. ;
Barker, Christopher A. ;
Mori, Shoko ;
Cordova, Miguel ;
Nehal, Kishwer S. ;
Rossi, Anthony M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (02) :303-317
[6]   Basal cell carcinoma Basal cell carcinoma Contemporary approaches to diagnosis, treatment, and prevention [J].
Cameron, Michael C. ;
Lee, Erica ;
Hibler, Brian P. ;
Giordano, Cerrene N. ;
Barker, Christopher A. ;
Mori, Shoko ;
Cordova, Miguel ;
Nehal, Kishwer S. ;
Rossi, Anthony M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (02) :321-339
[7]   Pembrolizumab with or without vismodegib in treating metastatic or unresectable basal cell skin cancer. [J].
Chang, Anne Lynn S. ;
Tran, Duy C. ;
Brotherton, Richard ;
Reddy, Sunil ;
Colevas, A. Dimitrios .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8]   Addressing overdiagnosis and overtreatment in cancer: a prescription for change [J].
Esserman, Laura J. ;
Thompson, Ian M. ;
Reid, Brian ;
Nelson, Peter ;
Ransohoff, David F. ;
Welch, H. Gilbert ;
Hwang, Shelley ;
Berry, Donald A. ;
Kinzler, Kenneth W. ;
Black, William C. ;
Bissell, Mina ;
Parnes, Howard ;
Srivastava, Sudhir .
LANCET ONCOLOGY, 2014, 15 (06) :E234-E242
[9]  
Firnhaber JM, 2012, AM FAM PHYSICIAN, V86, P161
[10]   Counterpoint: Limited life expectancy, basal cell carcinoma, health care today, and unintended consequences [J].
Fosko, Scott W. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :162-164